NCT05712187: An ongoing trial by Alto Neuroscience
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 4 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05712187 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled Study of ALTO-100 With an Open-Label Extension in Adults With Major Depressive Disorder |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 10, 2023 |
| Completion date | Sept. 5, 2024 |
| Required reporting date | Sept. 5, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 23, 2026 |
| Days late | None |